This is a Validated Antibody Database (VAD) review about human KRT13, based on 87 published articles (read how Labome selects the articles), using KRT13 antibody in all methods. It is aimed to help Labome visitors find the most suited KRT13 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KRT13 synonym: CK13; K13; WSN2

Invitrogen
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen KRT13 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen KRT13 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen KRT13 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen KRT13 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen KRT13 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen KRT13 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen KRT13 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen KRT13 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen KRT13 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (AE8)
  • immunohistochemistry - paraffin section; mouse; 1:500; fig 1
In order to characterize the spontaneous peripheral squamous cell lung cancer in mice by ablation of liver X receptors alpha and beta, Invitrogen KRT13 antibody (Thermo Fisher Scientific, MA1-5764) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen KRT13 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen KRT13 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen KRT13 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig s3
In order to determine how sensitivity is restored in resistant ovarian cancer cells by targeting the Ras-MAPK pathway by miR-634, Invitrogen KRT13 antibody (Neomarkers, MS-343-P) was used in immunohistochemistry on human samples (fig s3). Mol Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen KRT13 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen KRT13 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen KRT13 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen KRT13 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen KRT13 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen KRT13 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen KRT13 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen KRT13 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; domestic horse; 1:100
In order to discuss using induced pluripotent stem cells to promote wound healing in various animals, Invitrogen KRT13 antibody (Fisher Scientific, MA1-82041) was used in immunocytochemistry on domestic horse samples at 1:100. Equine Vet J (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen KRT13 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen KRT13 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; zebrafish ; 1:100; fig 5
In order to report that mice and zebrafish exposed to high-fat or high-cholesterol diets develop acute innate inflammatory responses in the intestine, Invitrogen KRT13 antibody (Thermo Fisher Scientific, MA1-82041) was used in flow cytometry on zebrafish samples at 1:100 (fig 5). Nat Commun (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen KRT13 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen KRT13 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen KRT13 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT13 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen KRT13 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen KRT13 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen KRT13 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen KRT13 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen KRT13 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen KRT13 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (2D7)
  • immunocytochemistry; human
In order to develop a telomerase-imortalized human primary gingival epithelial cell line, Invitrogen KRT13 antibody (Thermo Scientific, 2D7) was used in immunocytochemistry on human samples . J Periodontal Res (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen KRT13 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen KRT13 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen KRT13 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine the suitability of PAXgene tissue fixation for (immuno)histological methods, Invitrogen KRT13 antibody (Neomarkers, MS 343-P) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2011) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 0.4 ug/ul; fig 1
In order to develop an in vitro model for experimental studies of cancer cell invasion, Invitrogen KRT13 antibody (NeoMarkers, MS-343) was used in immunohistochemistry on human samples at 0.4 ug/ul (fig 1). Eur J Oral Sci (2010) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT13 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen KRT13 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen KRT13 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen KRT13 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT13 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen KRT13 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen KRT13 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen KRT13 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
domestic rabbit monoclonal (EPR3671)
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig 3b
Abcam KRT13 antibody (Abcam, AB92551) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig 3b). Cell Mol Gastroenterol Hepatol (2021) ncbi
mouse monoclonal (AE8)
  • immunocytochemistry; human; loading ...; fig 4c
Abcam KRT13 antibody (Abcam, AE8) was used in immunocytochemistry on human samples (fig 4c). Sci Rep (2018) ncbi
domestic rabbit monoclonal (EPR3671)
  • western blot; human; 1:5000; fig 5
Abcam KRT13 antibody (Epitomics, 2713-1) was used in western blot on human samples at 1:5000 (fig 5). Oncotarget (2016) ncbi
mouse monoclonal (AE8)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to assess the effect of Notch1 inactivation in oroesophageal epithelium, Abcam KRT13 antibody (Abcam, AE8) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Biochem Biophys Res Commun (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-3)
  • immunohistochemistry; mouse; loading ...; fig s2b
Santa Cruz Biotechnology KRT13 antibody (Santa Cruz Biotechnology, sc-390982) was used in immunohistochemistry on mouse samples (fig s2b). Cell Death Differ (2020) ncbi
mouse monoclonal (DE-K13)
  • immunocytochemistry; human; 1:400; loading ...; fig 3f
In order to optimize conditions to generate human pluripotent stem cell-derived limbal epithelial stem cells, Santa Cruz Biotechnology KRT13 antibody (Santa Cruz, sc-6258) was used in immunocytochemistry on human samples at 1:400 (fig 3f). Exp Eye Res (2016) ncbi
mouse monoclonal (AE8)
  • immunohistochemistry - frozen section; domestic rabbit
  • western blot; domestic rabbit
Santa Cruz Biotechnology KRT13 antibody (Santa Cruz, sc-57003) was used in immunohistochemistry - frozen section on domestic rabbit samples and in western blot on domestic rabbit samples . Tissue Eng Part A (2014) ncbi
MilliporeSigma
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2h
MilliporeSigma KRT13 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2h). J Clin Invest (2021) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Cancer Immunol Immunother (2020) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:50; fig 3a
MilliporeSigma KRT13 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry on mouse samples at 1:50 (fig 3a). Science (2018) ncbi
mouse monoclonal (KS-1A3)
  • immunocytochemistry; human; fig 2a
MilliporeSigma KRT13 antibody (Sigma, C0791) was used in immunocytochemistry on human samples (fig 2a). PLoS ONE (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - frozen section; mouse; 1:500; fig s4a
In order to discover that myoepithelial cells born early during submucosal gland morphogenesis are multipotent progenitors with the capacity to differentiate into other glandular cell types, MilliporeSigma KRT13 antibody (Sigma-Aldrich, C2562) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig s4a). Am J Respir Cell Mol Biol (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; mouse; fig 6
In order to study the role of Tsc2 in normal and pathological kidney and lung functions, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on mouse samples (fig 6). Am J Pathol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 2a
In order to test if metastasis can be reduced by targeting cancer-associated fibroblasts with Pirfenidone, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; loading ...; fig s5a
In order to study how tumor hypoxia affects DNA methylation, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples (fig s5a). Nature (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; pigs ; 1:100; loading ...; fig 5h
In order to build and characterize a novel bioreactor platform, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on pigs samples at 1:100 (fig 5h). Biotechnol J (2017) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:200
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:200. Nat Commun (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; loading ...; fig 2b
MilliporeSigma KRT13 antibody (Sigma, c2562) was used in immunohistochemistry on human samples (fig 2b). Nat Biotechnol (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; human; 1:200; fig 5
MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunocytochemistry on human samples at 1:200 (fig 5). BMC Biol (2016) ncbi
mouse monoclonal (KS-1A3)
  • immunohistochemistry; human; 4.94 ug/ml; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, MilliporeSigma KRT13 antibody (Sigma, C0791) was used in immunohistochemistry on human samples at 4.94 ug/ml (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; human; 1:4000; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry on human samples at 1:4000 (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; fig 2
In order to characterize induction of lactation-specific tight junctions concurrent with beta-casein expression in mammary epithelial cells due to prolactin and glucocorticoid signaling, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples (fig 2). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to study a model of immune functions of the mouse blood-cerebrospinal fluid barrier in vitro using primary epithelial cells better suited to study immune cell migration across the brain barrier, MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). Fluids Barriers CNS (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:400; fig 2
MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 2). Clin Cancer Res (2016) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunocytochemistry; mouse
MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunocytochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry; mouse; 1:800; fig 5
MilliporeSigma KRT13 antibody (Sigma, C2562) was used in immunohistochemistry on mouse samples at 1:800 (fig 5). Dis Model Mech (2015) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • immunohistochemistry - paraffin section; human; 1:2000
In order to develop and validate a mouse model of endometriosis, MilliporeSigma KRT13 antibody (Sigma-Aldrich, #C2562) was used in immunohistochemistry - paraffin section on human samples at 1:2000. Am J Pathol (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; rat
MilliporeSigma KRT13 antibody (Sigma, C2562) was used in western blot on rat samples . Carcinogenesis (2014) ncbi
mouse monoclonal (KS-1A3)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:100
MilliporeSigma KRT13 antibody (Sigma-Aldrich, KS-1A3) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:100. Biomaterials (2014) ncbi
mouse monoclonal (C-11+PCK-26+CY-90+KS-1A3+M20+A53-B/A2)
  • western blot; pigs
  • western blot; human; 1:10000
MilliporeSigma KRT13 antibody (Sigma-Aldrich, C 2562) was used in western blot on pigs samples and in western blot on human samples at 1:10000. Mol Oncol (2014) ncbi
Leica Biosystems
mouse monoclonal (KS-1A3)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 2f
Leica Biosystems KRT13 antibody (Novocastra, NCL-LL002) was used in immunohistochemistry - paraffin section on rat samples (fig 2f). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (KS-1A3)
  • immunohistochemistry; dogs; 1:50; fig S1c,S2c,S3c,S4c
In order to characterize an atypical cutaneous tumor of a 9-year-old mixed breed female dog, Leica Biosystems KRT13 antibody (Leica, NCL-LL002) was used in immunohistochemistry on dogs samples at 1:50 (fig S1c,S2c,S3c,S4c). J Vet Med Sci (2017) ncbi
mouse monoclonal (KS-1A3)
  • immunohistochemistry - paraffin section; human; 1:20; fig 1
In order to classify triple-negative breast cancer into subtypes, Leica Biosystems KRT13 antibody (Novocastra, NCL-LL002) was used in immunohistochemistry - paraffin section on human samples at 1:20 (fig 1). Oncol Lett (2016) ncbi
mouse monoclonal (KS-1A3)
  • immunohistochemistry; human; 1:200; tbl 1
Leica Biosystems KRT13 antibody (Novocastra, LL 002) was used in immunohistochemistry on human samples at 1:200 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
Articles Reviewed
  1. DeLaForest A, Kohlnhofer B, Franklin O, Stavniichuk R, Thompson C, Pulakanti K, et al. GATA4 Controls Epithelial Morphogenesis in the Developing Stomach to Promote Establishment of Glandular Columnar Epithelium. Cell Mol Gastroenterol Hepatol. 2021;12:1391-1413 pubmed publisher
  2. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  3. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  4. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  5. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  6. Fong L, Taccioli C, Palamarchuk A, Tagliazucchi G, Jing R, Smalley K, et al. Abrogation of esophageal carcinoma development in miR-31 knockout rats. Proc Natl Acad Sci U S A. 2020;117:6075-6085 pubmed publisher
  7. Costanzo Garvey D, Keeley T, Case A, Watson G, Alsamraae M, Yu Y, et al. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunol Immunother. 2020;69:1113-1130 pubmed publisher
  8. Sanz Gómez N, de Pedro I, Ortigosa B, Santamaria D, Malumbres M, de Carcer G, et al. Squamous differentiation requires G2/mitosis slippage to avoid apoptosis. Cell Death Differ. 2020;27:2451-2467 pubmed publisher
  9. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  10. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  11. Hayashi R, Ishikawa Y, Katayama T, Quantock A, Nishida K. CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells. Sci Rep. 2018;8:16550 pubmed publisher
  12. Pereira E, Kedrin D, Seano G, Gautier O, Meijer E, Jones D, et al. Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science. 2018;359:1403-1407 pubmed publisher
  13. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  14. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  15. Saha D, Koli S, Patgaonkar M, Reddy K. Expression of hemoglobin-α and β subunits in human vaginal epithelial cells and their functional significance. PLoS ONE. 2017;12:e0171084 pubmed publisher
  16. Watanabe K, Chambers J, Uchida K, Nibe K, Ushio N, Horiuchi N, et al. A cutaneous mixed tumor in a dog. J Vet Med Sci. 2017;79:670-673 pubmed publisher
  17. Anderson P, Lynch T, Engelhardt J. Multipotent Myoepithelial Progenitor Cells Are Born Early during Airway Submucosal Gland Development. Am J Respir Cell Mol Biol. 2017;56:716-726 pubmed publisher
  18. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  19. Ren S, Luo Y, Chen H, Warburton D, Lam H, Wang L, et al. Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization. Am J Pathol. 2016;186:3261-3272 pubmed publisher
  20. Takai K, Le A, Weaver V, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7:82889-82901 pubmed publisher
  21. Thienpont B, Steinbacher J, Zhao H, D Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63-68 pubmed publisher
  22. Schuerlein S, Schwarz T, Krziminski S, Gätzner S, Hoppensack A, Schwedhelm I, et al. A versatile modular bioreactor platform for Tissue Engineering. Biotechnol J. 2017;12: pubmed publisher
  23. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  24. Liu Y, Wang K, Xing H, Zhai X, Wang L, Wang W. Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers. Oncol Lett. 2016;12:1240-1256 pubmed
  25. Chen H, Wei Z, Sun J, Bhattacharya A, Savage D, Serda R, et al. A recellularized human colon model identifies cancer driver genes. Nat Biotechnol. 2016;34:845-51 pubmed publisher
  26. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  27. Dai Y, Miao Y, Wu W, Li Y, D Errico F, Su W, et al. Ablation of Liver X receptors ? and ? leads to spontaneous peripheral squamous cell lung cancer in mice. Proc Natl Acad Sci U S A. 2016;113:7614-9 pubmed publisher
  28. Toneff M, Sreekumar A, Tinnirello A, Hollander P, Habib S, Li S, et al. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016;14:47 pubmed publisher
  29. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  30. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  31. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  32. Kobayashi K, Tsugami Y, Matsunaga K, Oyama S, Kuki C, Kumura H. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with ?-casein expression in mammary epithelial cells. Biochim Biophys Acta. 2016;1863:2006-16 pubmed publisher
  33. Wang Z, Xie J, Yan M, Wang J, Wang X, Zhang J, et al. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma. Oncotarget. 2016;7:26765-79 pubmed publisher
  34. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed publisher
  35. Mandasari M, Sawangarun W, Katsube K, Kayamori K, Yamaguchi A, Sakamoto K. A facile one-step strategy for the generation of conditional knockout mice to explore the role of Notch1 in oroesophageal tumorigenesis. Biochem Biophys Res Commun. 2016;469:761-7 pubmed publisher
  36. Mikhailova A, Ilmarinen T, Ratnayake A, Petrovski G, Uusitalo H, Skottman H, et al. Human pluripotent stem cell-derived limbal epithelial stem cells on bioengineered matrices for corneal reconstruction. Exp Eye Res. 2016;146:26-34 pubmed publisher
  37. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  38. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  39. van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196 pubmed publisher
  40. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  41. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  42. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  43. Hurley P, Sundi D, Shinder B, Simons B, Hughes R, Miller R, et al. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2016;22:448-58 pubmed publisher
  44. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  45. Yuri S, Nishikawa M, Yanagawa N, Jo O, Yanagawa N. Maintenance of Mouse Nephron Progenitor Cells in Aggregates with Gamma-Secretase Inhibitor. PLoS ONE. 2015;10:e0129242 pubmed publisher
  46. Berry R, Ozdemir D, Aronow B, Lindström N, Dudnakova T, Thornburn A, et al. Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice. Dis Model Mech. 2015;8:903-17 pubmed publisher
  47. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  48. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  49. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  50. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  51. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  52. Aguiar C, Therrien J, Lemire P, Segura M, Smith L, Theoret C. Differentiation of equine induced pluripotent stem cells into a keratinocyte lineage. Equine Vet J. 2016;48:338-45 pubmed publisher
  53. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  54. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  55. Progatzky F, Sangha N, Yoshida N, McBrien M, Cheung J, Shia A, et al. Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat Commun. 2014;5:5864 pubmed publisher
  56. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  57. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  58. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  59. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  60. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  61. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  62. Greaves E, Cousins F, Murray A, Esnal Zufiaurre A, Fassbender A, Horne A, et al. A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium. Am J Pathol. 2014;184:1930-9 pubmed publisher
  63. Ryszawy D, Sarna M, Rak M, Szpak K, Kedracka Krok S, Michalik M, et al. Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer. Carcinogenesis. 2014;35:1920-30 pubmed publisher
  64. Liu Z, Yu N, Holz F, Yang F, Stanzel B. Enhancement of retinal pigment epithelial culture characteristics and subretinal space tolerance of scaffolds with 200 nm fiber topography. Biomaterials. 2014;35:2837-50 pubmed publisher
  65. Stratmann A, Fecher D, Wangorsch G, Göttlich C, Walles T, Walles H, et al. Establishment of a human 3D lung cancer model based on a biological tissue matrix combined with a Boolean in silico model. Mol Oncol. 2014;8:351-65 pubmed publisher
  66. Li H, Xu Y, Xie H, Li C, Song L, Feng C, et al. Epithelial-differentiated adipose-derived stem cells seeded bladder acellular matrix grafts for urethral reconstruction: an animal model. Tissue Eng Part A. 2014;20:774-84 pubmed publisher
  67. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  68. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  69. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  70. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  71. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  72. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  73. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  74. Moffatt Jauregui C, Robinson B, de Moya A, Brockman R, Roman A, Cash M, et al. Establishment and characterization of a telomerase immortalized human gingival epithelial cell line. J Periodontal Res. 2013;48:713-21 pubmed publisher
  75. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  76. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  77. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  78. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  79. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  80. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, et al. Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS ONE. 2011;6:e27704 pubmed publisher
  81. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed publisher
  82. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  83. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  84. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  85. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  86. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  87. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed